Scleroderma and IgG4-Related Disease

被引:10
|
作者
Reddi, Deepti M. [1 ]
Cardona, Diana M. [1 ]
Burchette, James L. [1 ]
Puri, Puja K. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[2] Lab Corp Amer, Res Triangle Pk, NC USA
关键词
IgG(4)-related disease; scleroderma; CREST syndrome; progressive systemic sclerosis; morphea; IGG4-RELATED SCLEROSING DISEASE; AUTOIMMUNE PANCREATITIS; SYSTEMIC-DISEASE; PROPOSAL; PATIENT; CANCER;
D O I
10.1097/DAD.0b013e318276cbac
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
IgG(4)-related disease is a syndrome which involves lymphoplasmacytic infiltrates and soft tissue sclerosis, elevated serum IgG(4) titer, and increased IgG(4)-positive plasma cells in a variety of tissues. Scleroderma is also characterized by fibrosis and lymphoplasmacytic infiltrates. To our knowledge, the presence of IgG(4)-positive cells has not been well characterized in scleroderma. A retrospective review of scleroderma and related disorders (calcinosis, raynaud's syndrome, esophageal dysmotility, sclerodactyly, telangiectasia (CREST) syndrome, progressive systemic sclerosis, morphea) was performed. Thirty-four cases of scleroderma and related disorders were identified; IgG(4)-positive and IgG-positive plasma cells were counted in 10 HPF and an IgG(4):IgG ratio determined. A cutoff ratio of 0.3 was used to define significant elevation. Three of the scleroderma cases had IgG(4):IgG greater than 0. Only 1 case had a significant elevation. Of the 3 cases with elevated ratio, IgG(4)-positive cells ranged from 2 to 64 (median = 14), with an IgG4: IgG ranging from 0.06 to 0.34 (median = 0.22). Similar results were produced with the other sclerosing disorders. These results suggest that scleroderma is not part of the IgG(4)-related disease spectrum.
引用
收藏
页码:458 / 462
页数:5
相关论文
共 50 条
  • [21] Management of orbital IgG4-related disease
    Glass, Lora R. Dagi
    Freitag, Suzanne K.
    CURRENT OPINION IN OPHTHALMOLOGY, 2015, 26 (06) : 491 - 497
  • [22] Neurological Manifestations of IgG4-Related Disease
    Baptista, Bernardo
    Casian, Alina
    Gunawardena, Harsha
    D'Cruz, David
    Rice, Claire M.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (04)
  • [23] IgG4-related disease: a clinical perspective
    Maritati, Federica
    Peyronel, Francesco
    Vaglio, Augusto
    RHEUMATOLOGY, 2020, 59 : 123 - 131
  • [24] IgG4-related kidney disease - A review
    Pradhan, Dinesh
    Pattnaik, Niharika
    Silowash, Russell
    Mohanty, Sambit Kumar
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (10) : 707 - 711
  • [25] The great mimicker: IgG4-related disease
    Alamino, Rodolfo Perez
    Espinoza, Luis R.
    Zea, Arnold H.
    CLINICAL RHEUMATOLOGY, 2013, 32 (09) : 1267 - 1273
  • [26] Cerebral involvement in IgG4-related disease
    Joshi, Deepak
    Jager, Rolf
    Hurel, Steven
    Pereira, Stephen P.
    Johnson, Gavin J.
    Chapman, Michael
    Fowler, Robert
    Winstanley, Alison
    Losseff, Nicholas
    Webster, George J. M.
    CLINICAL MEDICINE, 2015, 15 (02) : 130 - 134
  • [27] IgG4-related Disease of the Head and Neck
    Bhatti, Rahat M.
    Stelow, Edward B.
    ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (01) : 10 - 16
  • [28] Diagnosis and management of IgG4-related disease
    Hegade, Vinod S.
    Sheridan, Maria B.
    Huggett, Matthew T.
    FRONTLINE GASTROENTEROLOGY, 2019, 10 (03) : 275 - 283
  • [29] Risk of malignancies in IgG4-related disease
    Yamamoto, Motohisa
    Takahashi, Hiroki
    Tabeya, Tetsuya
    Suzuki, Chisako
    Naishiro, Yasuyoshi
    Ishigami, Keisuke
    Yajima, Hidetaka
    Shimizu, Yui
    Obara, Mikiko
    Yamamoto, Hiroyuki
    Himi, Tetsuo
    Imai, Kohzoh
    Shinomura, Yasuhisa
    MODERN RHEUMATOLOGY, 2012, 22 (03) : 414 - 418
  • [30] IgG4-related sclerosing disease
    Kamisawa, Terumi
    Okamoto, Atsutake
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (25) : 3948 - 3955